Qi-Lun Lai

Dr. Qi-Lun Lai

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
YZYin-Xi Zhang
Yin-Xi Zhang
CSChun-Hong Shen
Chun-Hong Shen
QLQi-Lun Lai
Qi-Lun Lai
GFGao-Li Fang
Gao-Li Fang
WMWen-Jie Ming
Wen-Jie Ming
MDMei-Ping Ding
Mei-Ping Ding

4 May 2016 in International Journal of Neuroscience
Verified
Journal Article
Closed access
SQSong Qiao
Song Qiao
YZYin-Xi Zhang
Yin-Xi Zhang
BZBi-Jun Zhang
Bi-Jun Zhang
RLRu-Yi Lu
Ru-Yi Lu
QLQi-Lun Lai
Qi-Lun Lai
JWJiong Wu
Jiong Wu
Purpose: Anti-gamma-aminobutyric acid B (anti-GABAB) receptor encephalitis is a newly described type of autoimmune encephalitis. We report a case series of patients diagnosed with anti-GABAB receptor encephalitis in China, focusing on their presentations, laboratory and imaging results, and outcomes, as well as the treatment strategies which were employed. Methods: Data from patients diagnosed with anti-GABAB receptor encephalitis in the Second Affiliated Hospital, School of Medicine, Zhejiang University, from January 2014 to June 2015 were retrospectively collected and analyzed. Based on specific diagnostic criteria, seven cases were included. Results: Six of the seven patients were males, and a median age at presentation of 56 years (range: 4–71 years). Seizures were the most common initial symptom, and all patients developed symptoms of typical limbic encephalitis during their disease course. Additional types of autoantibodies were identified in four patients. After presentation, three patients were found to have small cell lung cancer and one patient was eventually diagnosed with thymoma. All patients accepted first-line immune therapy, but only one chose tumor treatment. The three tumor-free patients had a good outcome, whereas those with tumors had a poor one. Finally, there were no relapses during follow-up. Conclusion: Anti-GABAB receptor encephalitis is a rare, unique autoimmune disease, and is often associated with tumors. It should be considered in the differential diagnosis for middle and senior-aged patients who present with predominantly limbic encephalitis symptoms. Importantly, earlier recognition of this potentially treatable condition could improve its overall prognosis.

1 January 2017 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
QLQi-Lun Lai
Qi-Lun Lai
CSChunhong Shen
Chunhong Shen
YZYang Zheng
Yang Zheng
YZYinxi Zhang
Yinxi Zhang
YGYi Guo
Yi Guo
MDMeiping Ding
Meiping Ding
Lai Q, et al. J Clin Neurol. 2017 Oct;13(4):371-379. https://doi.org/10.3988/jcn.2017.13.4.371

6 July 2022 in Clinical Immunology
Verified
Journal Article
Closed access
ELEr-Chuang Li
Er-Chuang Li
QLQi-Lun Lai
Qi-Lun Lai
MCMeng-Ting Cai
Meng-Ting Cai
YZYang Zheng
Yang Zheng
GFGao-Li Fang
Gao-Li Fang
YZYin-Xi Zhang
Yin-Xi Zhang

21 December 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MCMeng-Ting Cai
Meng-Ting Cai
YZYang Zheng
Yang Zheng
SWSa Wang
Sa Wang
QLQi-Lun Lai
Qi-Lun Lai
GFGao-Li Fang
Gao-Li Fang
MDMei-Ping Ding
Mei-Ping Ding
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is the most common autoimmune encephalitis. To date, there has been no study on the relationship between antibody (Ab) titers and clinical phenotype. This study aims to clarify the relationship between cerebrospinal fluid Ab titers and clinical manifestations of anti-NMDAR encephalitis at onset. Seventy-six consecutive patients with a definite diagnosis were enrolled. The relationship between Ab titers and different onset symptoms including psychiatric symptoms, seizures, and memory deficits were analyzed. We further investigated the correlation between Ab titers and clinical severity as assessed by the modified Rankin scale (mRS) and the clinical assessment scale for autoimmune encephalitis (CASE), respectively. The Ab titers had a median value of 1:10 (range 1:1–1:100). There was no significant difference in titers among various clinical factors including gender and combination of tumor and other diseases (each p > 0.05). Patients presenting with psychiatric symptoms at onset had higher titers than those with seizures (p = 0.008) and memory deficits (p = 0.003). The mRS scores revealed a significant but weak correlation with Ab titers (r = 0.243, p = 0.034), while CASE scores did not correlate with the titers (p = 0.125). Our findings indicated that the Ab titers were associated with the type of onset symptoms, with a higher level of patients with psychiatric symptoms. Regarding the clinical severity, the titers showed a weak correlation with the mRS, but no correlation with the CASE.

1 March 2025 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
ELEr-Chuang Li
Er-Chuang Li
TZTian-Yi Zhang
Tian-Yi Zhang
MCMeng-Ting Cai
Meng-Ting Cai
SSSheng-Yao Su
Sheng-Yao Su
CSChun-Hong Shen
Chun-Hong Shen
YZYin-Xi Zhang
Yin-Xi Zhang
In dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, DPPX antibodies from serum and CSF target the extracellular subunit of the voltage-gated potassium channel 4.2. This targeting leads to a characteristic clinical triad comprising gastrointestinal symptoms (predominantly diarrhea), cognitive-psychiatric dysfunction, and manifestations of CNS hyperexcitability, with hyperekplexia being a more specific feature. This rare disease typically presents with a subacute or chronic course and often affects middle-aged and older individuals. Patients may have a weak association with certain hematologic malignancies, particularly lymphoma and chronic lymphocytic leukemia. Brain MRI typically shows normal findings or nonspecific white matter changes. DPPX antibody-associated encephalitis responds well to immunotherapy, and most patients ultimately present with a good prognosis. However, relapses can occur. To improve our understanding of this rare but treatable autoimmune encephalitis and avoid misdiagnosis, we conduct a systematic review and summarize the current knowledge of its clinical and paraclinical features, management, and prognosis.